Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulli Rothweiler

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biological Chemistry|October 25, 2012
Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery toolEspen Åberg, Bjarte Lund, Alexander Pflug, et al.
Chemmedchem|April 23, 2008
Isoquinolin-1-one inhibitors of the MDM2-p53 interactionUlli Rothweiler, Anna Czarna, Marcin Krajewski, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down SyndromeWenche Stensen, Ulli Rothweiler, Richard Alan Engh, et al.
Cells|September 28, 2021
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin HomeostasisAgata Barzowska, Barbara Pucelik, Katarzyna Pustelny, et al.
Biotechnology Journal|March 26, 2024
R2D ligase: Unveiling a novel DNA ligase with surprising DNA-to-RNA ligation activitySigurd Eidem Gundesø, Ulli Rothweiler, Elise Heimland, et al.
Nucleic Acids Research|September 13, 2024
Using nucleolytic toxins as restriction enzymes enables new RNA applicationsUlli Rothweiler, Sigurd Eidem Gundesø, Emma Wu Mikalsen, et al.
Journal of Medicinal Chemistry|August 11, 2018
Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) InhibitorsAnna Czarna, Jinhua Wang, Diana Zelencova, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biological Chemistry|October 25, 2012
Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery toolEspen Åberg, Bjarte Lund, Alexander Pflug, et al.
Chemmedchem|April 23, 2008
Isoquinolin-1-one inhibitors of the MDM2-p53 interactionUlli Rothweiler, Anna Czarna, Marcin Krajewski, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down SyndromeWenche Stensen, Ulli Rothweiler, Richard Alan Engh, et al.
Cells|September 28, 2021
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin HomeostasisAgata Barzowska, Barbara Pucelik, Katarzyna Pustelny, et al.
Biotechnology Journal|March 26, 2024
R2D ligase: Unveiling a novel DNA ligase with surprising DNA-to-RNA ligation activitySigurd Eidem Gundesø, Ulli Rothweiler, Elise Heimland, et al.
Nucleic Acids Research|September 13, 2024
Using nucleolytic toxins as restriction enzymes enables new RNA applicationsUlli Rothweiler, Sigurd Eidem Gundesø, Emma Wu Mikalsen, et al.
Journal of Medicinal Chemistry|August 11, 2018
Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) InhibitorsAnna Czarna, Jinhua Wang, Diana Zelencova, et al.
Pageof 3